FDA Adverse Event
Injury
Summary report: N
OPTUNE GIO
MDR report key: 22780297
·
Received August 12, 2025
Report
- Report Number
- 3010457505-2025-00561
- Event Type
- Injury
- Date Received
- August 12, 2025
- Date of Event
- July 18, 2025
- Report Date
- August 12, 2025
- Manufacturer
- NOVOCURE GMBH
- Product Code
- NZK
- UDI-DI
- 07290107986427
- PMA / PMN Number
- P100034
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- US
- Reporter Occupation
- OTHER
Narratives
Additional Manufacturer Narrative · 0
NOVOCURE MEDICAL OPINION IS THAT THE WEIGHT OF CARRYING THE OPTUNE GIO DEVICE MAY HAVE CONTRIBUTED TO THE LOWER BACK PAIN. BACK PAIN IS AN EXPECTED EVENT WITH OPTUNE GIO DEVICE USE (EF-11 2% AND 10% EF-14 OPTUNE ARM).
Description of Event or Problem · 0
A 49-YEAR-OLD FEMALE PATIENT WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) STARTED OPTUNE GIO ON (B)(6) 2024. ON (B)(6) 2025, THE PATIENT REPORTED EXPERIENCING SEVERE LOWER BACK PAIN AND NOTED THAT WEARING THE OPTUNE GIO DEVICE APPEARED TO BE CONTRIBUTING TO HER SYMPTOMS. AS A RESULT, SHE HAD BEEN UNDERGOING PHYSICAL THERAPY. OPTUNE GIO THERAPY WAS TEMPORARILY DISCONTINUED. ATTEMPTS TO CONTACT THE PRESCRIBING PHYSICIAN FOR FURTHER DETAILS WERE MADE, ALTHOUGH NO RESPONSE WAS RECEIVED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2270420 | OPTUNE GIO | OPTUNE GIO | NZK | NOVOCURE GMBH | TFH9100 | 07290107986427 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 49 YR | Female | Required Intervention | BUPRENORPHINE TRANSDERMAL PATCH| LORAZEPAM| ONDANSETRON| PROCHLORPERAZINE |